HUTCHMED (China) Ltd.

11/24/2021 | Press release | Distributed by Public on 11/24/2021 05:40

HUTCHMED and AstraZeneca Initiate SACHI Phase III Trial of ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients in China After Progression on EGFR Inhibitor[...]